Hayashi, F.; Shigemura, K.; Maeda, K.; Hiraoka, A.; Maeshige, N.; Ooya, T.; Sung, S.-Y.; Yang, Y.-M.; Fujisawa, M.
Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer. J. Clin. Med. 2022, 11, 2448.
https://doi.org/10.3390/jcm11092448
AMA Style
Hayashi F, Shigemura K, Maeda K, Hiraoka A, Maeshige N, Ooya T, Sung S-Y, Yang Y-M, Fujisawa M.
Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer. Journal of Clinical Medicine. 2022; 11(9):2448.
https://doi.org/10.3390/jcm11092448
Chicago/Turabian Style
Hayashi, Fuuka, Katsumi Shigemura, Koki Maeda, Aya Hiraoka, Noriaki Maeshige, Tooru Ooya, Shian-Ying Sung, Yong-Ming Yang, and Masato Fujisawa.
2022. "Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer" Journal of Clinical Medicine 11, no. 9: 2448.
https://doi.org/10.3390/jcm11092448
APA Style
Hayashi, F., Shigemura, K., Maeda, K., Hiraoka, A., Maeshige, N., Ooya, T., Sung, S.-Y., Yang, Y.-M., & Fujisawa, M.
(2022). Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer. Journal of Clinical Medicine, 11(9), 2448.
https://doi.org/10.3390/jcm11092448